Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Lancet
    October 2017
  1. SU M, Zhang Q, Bai X, Wu C, et al
    Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32476.
    >> Share

  2. HESKETH T, Zhou X
    Hypertension in China: the gap between policy and practice.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32743.
    >> Share

  3. LU J, Lu Y, Wang X, Li X, et al
    Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32478.
    >> Share

    September 2017
  4. SPIERING W, Williams B, Van der Heyden J, van Kleef M, et al
    Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32337.
    >> Share

  5. COURAND PY, Lantelme P
    Stretching the carotid sinus to treat resistant hypertension.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32298.
    >> Share

    August 2017
  6. AZIZI M
    Catheter-based renal denervation for treatment of hypertension.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32293.
    >> Share

  7. TOWNSEND RR, Mahfoud F, Kandzari DE, Kario K, et al
    Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32281.
    >> Share

    July 2017
  8. RODGERS A, Chow CK, Thakkar J, Bennett A, et al
    A personalised or procrustean approach to treating hypertension? - Authors' reply.
    Lancet. 2017;390:27-28.
    >> Share

  9. GABB GM, Mol PGM, Arnolda LF
    A personalised or procrustean approach to treating hypertension?
    Lancet. 2017;390:26-27.
    >> Share

    June 2017
  10. MUNDLE S, Bracken H, Khedikar V, Mulik J, et al
    Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31367.
    >> Share

  11. SURI V, Sikka P
    Oral misoprostol for induction of labour in hypertensive pregnancies.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31453.
    >> Share

    March 2017
  12. LUYCKX VA, Perico N, Somaschini M, Manfellotto D, et al
    A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group.
    Lancet. 2017 Mar 8. pii: S0140-6736(17)30576.
    >> Share

    February 2017
  13. GRADMAN AH
    A quarter-dose quadpill for initial treatment of hypertension.
    Lancet. 2017 Feb 9. pii: S0140-6736(17)30331.
    >> Share

  14. CHOW CK, Thakkar J, Bennett A, Hillis G, et al
    Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
    Lancet. 2017 Feb 9. pii: S0140-6736(17)30260.
    >> Share

    January 2017
  15. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    Hypertension control and cardiovascular disease - Authors' reply.
    Lancet. 2017;389:154-155.
    >> Share

  16. JAMES JE
    Hypertension control and cardiovascular disease.
    Lancet. 2017;389:154.
    >> Share

  17. MESSERLI FH, Fischer U, Rimoldi SF, Bangalore S, et al
    Hypertension control and cardiovascular disease.
    Lancet. 2017;389:153.
    >> Share

  18. ZENG X, Deng A, Ding Y
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35.
    >> Share

    December 2016
  19. SLIWA K
    The heart of Africa: succeeding against the odds.
    Lancet. 2016;388:e28-e36.
    >> Share

    October 2016
  20. SCHOFIELD G, Henderson G, Crofts C
    Beyond salt-where next for hypertension epidemiology?
    Lancet. 2016;388:2110-2111.
    >> Share

  21. MENTE A, O'Donnell MJ, Yusuf S
    Sodium and cardiovascular disease - Authors' reply.
    Lancet. 2016;388:2113-2114.
    >> Share

  22. CAPPUCCIO FP
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112.
    >> Share

  23. KATZ J
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112-2113.
    >> Share

  24. STRAZZULLO P, Giampaoli S, Iacoviello L, Rossi L, et al
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111.
    >> Share

  25. WALD N, Law M
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111-2112.
    >> Share

  26. ALDERMAN MH
    Dietary sodium: paradigm shifts from public health to clinical medicine.
    Lancet. 2016;388:2110.
    >> Share


  27. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1659-1724.
    >> Share

    September 2016
  28. WATTS G
    Neil Poulter: upping the pressure on hypertension.
    Lancet. 2016 Sep 29. pii: S0140-6736(16)31775.
    >> Share

  29. OLSEN MH, Angell SY, Asma S, Boutouyrie P, et al
    A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.
    Lancet. 2016 Sep 22. pii: S0140-6736(16)31134.
    >> Share

    August 2016
  30. MANCIA G
    Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease?
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31398.
    >> Share

  31. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    >> Share

  32. WALLENTIN L, Lindhagen L, Arnstrom E, Husted S, et al
    Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31276.
    >> Share

    July 2016
  33. KAIN K
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:126.
    >> Share

  34. ETTEHAD D, Emdin CA, Kiran A, Rahimi K, et al
    Blood pressure lowering for cardiovascular disease - Authors' reply.
    Lancet. 2016;388:126-7.
    >> Share

  35. O'KEEFFE DT, Maraka S
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125.
    >> Share

  36. SMULDERS YM, Muller M
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125-6.
    >> Share

  37. COLLINS DR, Albasri A, O'Sullivan J, Bobrovitz N, et al
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125.
    >> Share

    June 2016
  38. SONODA Y, Higuchi A, Morita T, Mori J, et al
    Intensive blood pressure lowering.
    Lancet. 2016;387:2291.
    >> Share

  39. XIE X, Atkins E, Lv J, Rodgers A, et al
    Intensive blood pressure lowering - Authors' reply.
    Lancet. 2016;387:2291.
    >> Share

    May 2016
  40. OK E, Asci G, Chazot C, Ozkahya M, et al
    Controversies and problems of volume control and hypertension in haemodialysis.
    Lancet. 2016 May 20. pii: S0140-6736(16)30389.
    >> Share

  41. MENTE A, O'Donnell M, Rangarajan S, Dagenais G, et al
    Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.
    Lancet. 2016 May 20. pii: S0140-6736(16)30467.
    >> Share

    April 2016
  42. WILLIAMS B, MacDonald TM, Morant SV, Brown MJ, et al
    PATHWAY-2: spironolactone for resistant hypertension - Authors' reply.
    Lancet. 2016;387:1373-4.
    >> Share

  43. DALE A, Hartley P, Goldacre B
    PATHWAY-2: spironolactone for resistant hypertension.
    Lancet. 2016;387:1372-3.
    >> Share

  44. GKALIAGKOUSI E, Gavriilaki E, Triantafyllou A, Douma S, et al
    PATHWAY-2: spironolactone for resistant hypertension.
    Lancet. 2016;387:1372.
    >> Share

  45. BOUTARI C, Stavropoulos K, Imprialos K, Doumas M, et al
    PATHWAY-2: spironolactone for resistant hypertension.
    Lancet. 2016;387:1371-2.
    >> Share

  46. ZALCMAN G, Mazieres J, Margery J, Greillier L, et al
    Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
    Lancet. 2016;387:1405-14.
    >> Share

    March 2016
  47. LAURENT S, Boutouyrie P
    Blood pressure lowering trials: wrapping up the topic?
    Lancet. 2016;387:923-4.
    >> Share

    February 2016
  48. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    >> Share

    January 2016
  49. BRUNSTROM M, Carlberg B
    Lower blood pressure targets: to whom do they apply?
    Lancet. 2016;387:405-6.
    >> Share

    December 2015
  50. ETTEHAD D, Emdin CA, Kiran A, Anderson SG, et al
    Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Lancet. 2015 Dec 23. pii: S0140-6736(15)01225.
    >> Share


  51. Health security: the defining challenge of 2016.
    Lancet. 2015;386:2445.
    >> Share

    November 2015
  52. LOBO MD, Sobotka PA, Dolan E, Witkowski A, et al
    Central arteriovenous anastomosis and hypertension - Authors' reply.
    Lancet. 2015;386:1821-2.
    >> Share

  53. DEINUM J, Wetzels JF
    Central arteriovenous anastomosis and hypertension.
    Lancet. 2015;386:1821.
    >> Share

  54. XIE X, Atkins E, Lv J, Bennett A, et al
    Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Lancet. 2015 Nov 7. pii: S0140-6736(15)00805.
    >> Share

    October 2015
  55. BROEKHUIJSEN K, Groen H, van den Berg PP, Mol BW, et al
    Gestational hypertension and advanced maternal age - Authors' reply.
    Lancet. 2015;386:1628.
    >> Share

  56. DIETL A, Farthmann J
    Gestational hypertension and advanced maternal age.
    Lancet. 2015;386:1627-8.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016